The main reason I bought this was a deep value.However, I feel like FRX overpaid for CLDA.Is it still value stock?
Go ahead get out.For me:"Viibryd coming to pharmacies second quarter 2011."You can search for the link using the above quote.Viibryd was recently approved by the FDA for treatment of major depressive disorder in adults."A bird in hand is worth two in the bush." Viibryd is approved recently which means a very long time on patent. New clinical trials will likely for expanded application and dose.